Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced it has received a patent (US Patent No. 12,364,680) covering KIO-104 for the treatment of a wide range of ocular diseases. This includes, but ...

New research paper highlights the unique structure and function of Nanoscope's synthetic opsin, supporting its potential in vision restoration DALLAS, ...

Looking ahead, Vision AI could serve as a frontline tool for broader disease detection. Ainnova’s future roadmap includes a cloud-connected retinal camera for rural clinics and new modules aimed at ...

Researchers demonstrated that systemic factors from young mice can rejuvenate the aging retina by alleviating cellular senescence and restoring function.

Like most human traits, blue eyes are determined by genes, and no two people have exactly the same hue. It works a lot like individual fingerprints, making our eyes two of the most distinctive parts ...

Optical Coherence Tomography (OCT) imaging is extensively utilized for non-invasive observation of pathological conditions, such as retinal fluid-associated diseases. Accurate fluid segmentation in ...

Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or ...

Emerging research positions TUDCA, a bile acid compound, as a promising neuroprotective agent against Alzheimer’s, ...

Darwinian evolution says that complex systems arise through numerous successive, slight modifications that benefit the species' survival over many generations. However, we have shown that bacterial fl ...

Accurate extraction of molecular representations is a critical step in the drug discovery process. In recent years, significant progress has been made in molecular representation learning methods, ...

Despite its prevalence, the exact molecular mechanisms underlying the damage to retinal pigment epithelial cells (RPEs) and photoreceptor cells (PCs) in dry AMD remain poorly understood. Hence, there ...

It's a strategic and scalable approach to one of the biggest gaps in modern healthcare: detecting chronic conditions like diabetic retinopathy before symptoms appear. Avant and Ainnova are now proving ...